Nonlesional Sources of Contrast Enhancement on Postgadolinium “Black-Blood” 3D T1-SPACE Images in Patients with Multiple Sclerosis

References

1. 1.↵
   2. Thompson AJ,
   3. Baranzini SE,
   4. Geurts J, et al

   . Multiple sclerosis. Lancet 2018;391:1622–36 doi:10.1016/S0140-6736(18)30481-1 pmid:29576504

   CrossRefPubMed
2. 2.↵
   2. Lublin FD,
   3. Reingold SC,
   4. Cohen JA, et al

   . Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014;83:278–86 doi:10.1212/WNL.0000000000000560 pmid:24871874

   CrossRefPubMed
3. 3.↵
   2. Río J,
   3. Rovira À,
   4. Tintoré M, et al

   . Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients. Mult Scler 2018;24:322–30 doi:10.1177/1352458517698052 pmid:28287331

   CrossRefPubMed
4. 4.↵
   2. Gasperini C,
   3. Prosperini L,
   4. Tintoré M, et al

   ; the MAGNIMS Study Group. Unraveling treatment response in multiple sclerosis: a clinical and MRI challenge. Neurology 2019;92:180–92 doi:10.1212/WNL.0000000000006810 pmid:30587516

   Abstract/FREE Full Text
5. 5.↵
   2. Bermel RA,
   3. You X,
   4. Foulds P, et al

   . Predictors of long-term outcome in multiple sclerosis patients treated with interferon β. Ann Neurol 2013;73:95–103 doi:10.1002/ana.23758 pmid:23378325

   CrossRefPubMed
6. 6.↵
   2. Prosperini L,
   3. Mancinelli C,
   4. Haggiag S, et al

   . Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2020;91:271–77 doi:10.1136/jnnp-2019-322348 pmid:31974130

   Abstract/FREE Full Text
7. 7.↵
   2. Mandell DM,
   3. Mossa-Basha M,
   4. Qiao Y, et al

   ; Vessel Wall Imaging Study Group of the American Society of Neuroradiology. Intracranial vessel wall MRI: principles and expert consensus recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol 2017;38:218–29 doi:10.3174/ajnr.A4893 pmid:27469212

   Abstract/FREE Full Text
8. 8.↵
   2. Thaler C,
   3. Schneider T,
   4. Sedlacik J, et al

   . T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis. PLoS One 2017;12:e0183099 doi:10.1371/journal.pone.0183099 pmid:28797082

   CrossRefPubMed
9. 9.↵
   2. Sommer NN,
   3. Saam T,
   4. Coppenrath E, et al

   . Multiple sclerosis: improved detection of active cerebral lesions with 3-dimensional T1 black-blood magnetic resonance imaging compared with conventional 3-dimensional T1 GRE imaging. Invest Radiol 2018;53:13–19 doi:10.1097/RLI.0000000000000410 pmid:28858894

   CrossRefPubMed
10. 10.↵
    2. Kato Y,
    3. Higano S,
    4. Tamura H, et al

    . Usefulness of contrast-enhanced T1-weighted sampling perfection with application-optimized contrasts by using different flip angle evolutions in detection of small brain metastasis at 3T MR imaging: comparison with magnetization-prepared rapid acquisition. AJNR Am J Neuroradiol 2009;30:923–29 doi:10.3174/ajnr.A1506 pmid:19213825

    Abstract/FREE Full Text
11. 11.↵
    2. Jeevanandham B,
    3. Kalyanpur T,
    4. Gupta P, et al

    . Comparison of post-contrast 3D-T1-MPRAGE, 3D-T1-SPACE and 3D-T2-FLAIR MR images in evaluation of meningeal abnormalities at 3-T MRI. Br J Radiol 2017;90:20160834 doi:10.1259/bjr.20160834 pmid:28375660

    CrossRefPubMed
12. 12.↵
    2. Hodel J,
    3. Outteryck O,
    4. Ryo E, et al

    . Accuracy of postcontrast 3D turbo spin-echo MR sequence for the detection of enhanced inflammatory lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol 2014;35:519–23 doi:10.3174/ajnr.A3795 pmid:24200899

    Abstract/FREE Full Text
13. 13.↵
    2. Brinjikji W,
    3. El-Rida El-Masri A,
    4. Wald JT, et al

    . Prevalence of developmental venous anomalies increases with age. Stroke 2017;48:1997–99 doi:10.1161/STROKEAHA.116.016145 pmid:28536179

    Abstract/FREE Full Text
14. 14.↵
    2. Grazzini I,
    3. Calchetti B,
    4. Cuneo GL

    . Developmental venous anomalies in patients with multiple sclerosis: is that a coincidence or an ancillary finding? Neurol Sci 2021;42:2453–60 doi:10.1007/s10072-020-04840-5 pmid:33083936

    CrossRefPubMed
15. 15.↵
    2. Bedell BJ,
    3. Narayana PA

    . Volumetric analysis of white matter, gray matter, and CSF using fractional volume analysis. Magn Reson Med 1998;39:961–69 doi:10.1002/mrm.1910390614 pmid:9621920

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Karimaghaloo Z,
    3. Shah M,
    4. Francis SJ, et al

    . Automatic detection of gadolinium-enhancing multiple sclerosis lesions in brain MRI using conditional random fields. IEEE Trans Med Imaging 2012;31:1181–94 doi:10.1109/TMI.2012.2186639 pmid:22318484

    CrossRefPubMed
17. 17.↵
    2. Coronado I,
    3. Gabr RE,
    4. Narayana PA

    . Deep learning segmentation of gadolinium-enhancing lesions in multiple sclerosis. Mult Scler 2021;27:519–27 doi:10.1177/1352458520921364 pmid:32442043

    CrossRefPubMed
18. 18.↵
    2. He R,
    3. Narayana PA

    . Automatic delineation of Gd enhancements on magnetic resonance images in multiple sclerosis. Med Phys 2002;29:1536–46 doi:10.1118/1.1487422 pmid:12148736

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Goldberg-Zimring D,
    3. Achiron A,
    4. Miron S, et al

    . Automated detection and characterization of multiple sclerosis lesions in brain MR images. Magn Reson Imaging 1998;16:311–18 doi:10.1016/s0730-725x(97)00300-7 pmid:9621972

    CrossRefPubMed
20. 20.↵
    2. Polman CH,
    3. Reingold SC,
    4. Banwell B, et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Granberg T,
    3. Martola J,
    4. Kristoffersen-Wiberg M, et al

    . Radiologically isolated syndrome–incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scler 2013;19:271–80 doi:10.1177/1352458512451943 pmid:22760099

    CrossRefPubMed
22. 22.↵
    2. Danieli L,
    3. Riccitelli GC,
    4. Distefano D, et al

    . Brain tumor-enhancement visualization and morphometric assessment: a comparison of MPRAGE, SPACE, and VIBE MRI techniques. AJNR Am J Neuroradiol 2019;40:1140–48 doi:10.3174/ajnr.A6096 pmid:31221635

    Abstract/FREE Full Text
23. 23.↵
    2. El-Koussy M,
    3. Schroth G,
    4. Gralla J, et al

    . Susceptibility-weighted MR imaging for diagnosis of capillary telangiectasia of the brain. AJNR Am J Neuroradiol 2012;33:715–20 doi:10.3174/ajnr.A2893 pmid:22194370

    Abstract/FREE Full Text
24. 24.↵
    2. Pravatà E,
    3. Roccatagliata L,
    4. Sormani MP, et al

    . Dedicated 3D-T2-STIR-ZOOMit imaging improves demyelinating lesion detection in the anterior visual pathways of patients with multiple sclerosis. AJNR Am J Neuroradiol 2021;42:1061–68 doi:10.3174/ajnr.A7082 pmid:33766824

    Abstract/FREE Full Text
25. 25.↵
    2. Geraldes R,
    3. Ciccarelli O,
    4. Barkhof F, et al

    ; MAGNIMS study group. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol 2018;14:199–213 doi:10.1038/nrneurol.2018.39 pmid:29582852

    CrossRefPubMed
26. 26.↵
    2. Filippi M,
    3. Preziosa P,
    4. Banwell BL, et al

    . Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 2019;142:1858–75 doi:10.1093/brain/awz144 pmid:31209474

    CrossRefPubMed
27. 27.↵
    2. Filippi M,
    3. Rocca MA,
    4. Ciccarelli O, et al

    . MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

    CrossRefPubMed
28. 28.↵
    2. Dobson R,
    3. Giovannoni G

    . Multiple sclerosis: a review. Eur J Neurol 2019;26:27–40 doi:10.1111/ene.13819 pmid:30300457

    CrossRefPubMed
29. 29.↵
    2. Kaufmann TJ,
    3. Smits M,
    4. Boxerman J, et al

    . Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol 2020;22:757–72 doi:10.1093/neuonc/noaa030 pmid:32048719

    CrossRefPubMed
30. 30.↵
    2. Goncalves Filho AL,
    3. Conklin J,
    4. Longo MG, et al

    . Accelerated post-contrast wave-CAIPI T1 SPACE achieves equivalent diagnostic performance compared with standard T1 SPACE for the detection of brain metastases in clinical 3T MRI. Front Neurol 2020;11:587327 doi:10.3389/fneur.2020.587327 pmid:33193054

    CrossRefPubMed
31. 31.↵
    2. Filippi M,
    3. Rocca MA,
    4. Barkhof F, et al

    ; Attendees of the Correlation between pathological and MRI findings in MS workshop. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 2012;11:349–60 doi:10.1016/S1474-4422(12)70003-0 pmid:30663609

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Santucci GM,
    3. Leach JL,
    4. Ying J, et al

    . Brain parenchymal signal abnormalities associated with developmental venous anomalies: detailed MR imaging assessment. AJNR Am J Neuroradiol 2008;29:1317–23 doi:10.3174/ajnr.A1090 pmid:18417603

    CrossRefPubMed
33. 33.↵
    2. Tsantes E,
    3. Curti E,
    4. Ganazzoli C, et al

    . The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary? J Neurol 2020;267:2642–47 doi:10.1007/s00415-020-09894-1 pmid:32399696

    CrossRefPubMed
34. 34.↵
    2. Sadigh G,
    3. Saindane AM,
    4. Waldman AD, et al

    . Comparison of unenhanced and gadolinium-enhanced imaging in multiple sclerosis: is contrast needed for routine follow-up MRI? AJNR Am J Neuroradiol 2019;40:1476–80 doi:10.3174/ajnr.A6179 pmid:31439627

    Abstract/FREE Full Text
35. 35.↵
    2. Mattay RR,
    3. Davtyan K,
    4. Bilello M, et al

    . Do all patients with multiple sclerosis benefit from the use of contrast on serial follow-up MR imaging? A retrospective analysis. AJNR Am J Neuroradiol 2018;39:2001–06 doi:10.3174/ajnr.A5828 pmid:30287455

    Abstract/FREE Full Text
36. 36.↵
    2. Xie Y,
    3. Yang Q,
    4. Xie G, et al

    . Improved black-blood imaging using DANTE-SPACE for simultaneous carotid and intracranial vessel wall evaluation. Magn Reson Med 2016;75:2286–94 doi:10.1002/mrm.25785 pmid:26152900

    CrossRefPubMed
37. 37.↵
    2. Kammer NN,
    3. Coppenrath E,
    4. Treitl KM, et al

    . Comparison of contrast-enhanced modified T1-weighted 3D TSE black-blood and 3D MP-RAGE sequences for the detection of cerebral metastases and brain tumours. Eur Radiol 2016;26:1818–25 doi:10.1007/s00330-015-3975-x pmid:26334511

    CrossRefPubMed